Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

Treatment of B-lymphoproliferative disorder with a monoclonal anti–interleukin-6 antibody in 12 patients: a multicenter phase 1-2 clinical trial

Blood (2001) 97 (6): 1590–1597.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals